• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt : Transjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters.

作者信息

Magaz Marta, García-Pagán Juan Carlos

机构信息

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital ClínicInstitut de Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, 08036, Barcelona, Spain.

CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas Y Digestivas), Barcelona, Spain.

出版信息

Hepatol Int. 2021 Jun;15(3):568-570. doi: 10.1007/s12072-021-10166-x. Epub 2021 Mar 17.

DOI:10.1007/s12072-021-10166-x
PMID:33733320
Abstract
摘要

相似文献

1
Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt : Transjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters.经颈静脉肝内门体分流术后吡咯烷生物碱诱导的肝窦阻塞综合征患者预后不良的危险因素：肝窦阻塞综合征患者的经颈静脉肝内门体分流术，病因很重要。
Hepatol Int. 2021 Jun;15(3):568-570. doi: 10.1007/s12072-021-10166-x. Epub 2021 Mar 17.
2
Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.吡咯烷生物碱诱导的肝窦阻塞综合征经颈静脉肝内门体分流术后预后不良的危险因素。
Hepatol Int. 2021 Jun;15(3):720-729. doi: 10.1007/s12072-020-10126-x. Epub 2021 Jan 28.
3
Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.经颈静脉肝内门体分流术治疗菊三七相关性肝窦阻塞综合征的获益：倾向评分匹配分析。
Cardiovasc Intervent Radiol. 2023 Jul;46(7):931-942. doi: 10.1007/s00270-023-03451-9. Epub 2023 May 24.
4
Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study.经颈静脉肝内门体分流术治疗吡咯里西啶生物碱诱导的肝窦阻塞综合征：一项回顾性队列研究。
Eur J Gastroenterol Hepatol. 2023 Sep 1;35(9):1004-1011. doi: 10.1097/MEG.0000000000002591. Epub 2023 Jun 16.
5
Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术成功治疗肾移植患者中严重的硫唑嘌呤诱导的肝静脉闭塞病
Clin Nephrol. 1998 Aug;50(2):118-22.
6
Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.经颈静脉肝内门体分流术治疗吡咯里西啶生物碱相关肝窦阻塞综合征。
World J Gastroenterol. 2020 Jun 28;26(24):3472-3483. doi: 10.3748/wjg.v26.i24.3472.
7
[Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt].经颈静脉肝内门体分流术治疗肝小静脉闭塞病严重程度分级对患者预后的预测研究
Zhonghua Gan Zang Bing Za Zhi. 2021 Jan 20;29(1):46-53. doi: 10.3760/cma.j.cn501113-20201213-00651.
8
Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征患者经颈静脉肝内门体分流术的时机和疗效。
Sci Rep. 2021 Nov 5;11(1):21743. doi: 10.1038/s41598-021-01201-w.
9
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征：发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
10
[Veno-occlusive disease of the liver and POEMS syndrome].[肝静脉闭塞病与POEMS综合征]
Presse Med. 1999 Feb 20;28(7):334-6.

本文引用的文献

1
Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.吡咯里西啶生物碱相关肝静脉闭塞病的临床特征和治疗。
Liver Int. 2018 Oct;38(10):1867-1874. doi: 10.1111/liv.13684. Epub 2018 Feb 11.